Trial intelligence / Profile preview

Effect of Mirtazapine on Aggression in Patients with Alzheimer

IRCT20210613051565N1Phase 3Completed

Sponsor
University of Social Welfare and Rehabilitation Sciences
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of mirtazapine in Alzheimer's disease (AD), sponsored by University of Social Welfare and Rehabilitation Sciences. Started Jul 2021; status: completed.

02

Drugs

mirtazapine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on IRCT20210613051565N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210613051565N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call